안녕하세요. 의정부 을지대병원에서 새로 진료를 시작하는 유순집 입니다. 만성질환은 단순히 치료하는 과정을 넘어, 환자의 일상을 건강하게 관리하는 긴 여정 입니다. 저는 만성질환으로 고통받는 여러분 목소리에 귀를 귀울이고, 그 아픔에 깊이 공감하는 따뜻한 의료 동행자가 되고자 합니다. 때로는 가족처럼, 때로는 든든한 파트너처럼 여러분의 곁에서 건강한 내일을 위해 끝까지 함께 걷겠습니다.
1. Kim MJ, Yoo SJ, Yoo S, Kwon MY, Lee S, Kim M. The Clinically Significant Changes in the Composition and Functional Diversity of the Vaginal Microbiome in Women with Type 2 Diabetes Mellitus. Microorganisms. 2025;13(6):1426. doi: 10.3390/microorganisms13061426.
2. Jeong IK, Choi KM, Han KA, Kim KA, Kim IJ, Han SJ, Lee WY, Yoo SJ. Efficacy and safety of dapagliflozin add-on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study. Diabetes Obes Metab. 2024 ;26(11):5065-5077.
3. Jo KH, Lee J, Yoo J, Kim HS, Kim ES, Han JH, Jang YS, Yun JS, Son JW, Yoo SJ, Lee SH, Lim DJ, Kwon HS, Lee S, Moon S, Kim M. Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review. Ann Lab Med. 2024 Nov 1;44(6):591-597.
4. Lee J, Kim HS, Song KH, Yoo SJ, Han K, Lee SH; Committee of Big Data, Korean Endocrine Society. Risk of Cause-Specific Mortality across Glucose Spectrum in Elderly People: A Nationwide Population-Based Cohort Study. Endocrinol Metab (Seoul). 2023 Sep 7. doi: 10.3803/EnM.2023.1765. Online ahead of print.
5. Kim MK, Han K, Kwon HS, Yoo SJ. Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matching Analysis. Endocrinol Metab (Seoul). 2023 Aug;38(4):426-435.
6. Lee BW, Min K, Hong EG, Ku BJ, Kang JG, Chon S, Lee WY, Park MK, Kim JH, Kim SY, Song K, Yoo SJ. Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION). Endocrinol Metab (Seoul). 2023 Jun;38(3):328-337.
7. Ku EJ, Song K, Kim KM, Seo GH, Yoo SJ. Mortality and Severity of Coronavirus Disease 2019 in Patients with Long-Term Glucocorticoid Therapy: A Korean Nationwide Cohort Study. Endocrinol Metab (Seoul). 2023 Apr;38(2):253-259.
8. Hong OK, Kim ES, Son JW, Kim SR, Yoo SJ, Kwon HS, Lee SS. Alcohol-induced increase in BMP levels promotes fatty liver disease in male prediabetic stage Otsuka Long-Evans Tokushima Fatty rats. J Cell Biochem. 2023 Mar;124(3):459-472.
9. Kim HS, Yu JM, Jang HC, Choi EK, Park JH, Shon HS, Chung CH, Park KG, Cho JH, Kim W, Lee KH, Lee JH, Yoo SJ. Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea. Diabetes Metab Syndr Obes. 2022 May 11;15:1495-1503.
10. Ku EJ, Lee C, Shim J, Lee S, Kim KA, Kim SW, Rhee Y, Kim HJ, Lim JS, Chung CH, Chun SW, Yoo SJ, Ryu OH, Cho HC, Hong AR, Ahn CH, Kim JH, Choi MH. Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in Korea. Endocrinol Metab (Seoul). 2021 Oct;36(5):1131-1141.
11. Kim BY, Kim B, Han K, Chon SJ, Yoo SJ, Kim KK; Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity. Pre-pregnancy metabolic syndrome and insulin administration in gestational diabetes: A nationwide population-based cohort study. Obes Res Clin Pract. 2021 Jul-Aug;15(4):362-367.
12. Hong OK, Lee SS, Yoo SJ, Choi SH, Lee MK, Cha BY, Kim MK, Baek KH, Song KH, Kwon HS. Effects of DA-9801 on the inflammation and apoptosis induced by angiotensin II in human dermal microvascular endothelial cells. J Pharmacol Sci. 2021 Jan;145(1):52-59.
13. Yoo SJ*, Chang SA, Sohn TS, Kwon HS, Lee JM, Moon S, Proot P, Paldánius PM, Yoon KH. Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Metab J. 2020 Nov 12. doi: 10.4093/dmj.2020.0173. Online ahead of print.
14. Koh ES, Han K, Nam YS, Wittbrodt ET, Fenici P, Kosiborod MN, Heerspink HJL, Yoo SJ, Kwon HS. Renal outcomes and all-cause death associated with sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL 3 Korea). Diabetes Obes Metab. 2021 Feb;23(2):455-466.
15. Nam GE, Kim YH, Han K, Jung JH, Park YG, Lee KW, Rhee EJ, Son JW, Lee SS, Kwon HS, Lee WY, Yoo SJ*. Obesity Fact Sheet in Korea, 2018: Data Focusing on Waist Circumference and Obesity-Related Comorbidities. J Obes Metab Syndr. 2019 Dec;28(4):236-245.
16. Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim KK, Kim BY, Kim YH, Kim WJ, Kim EM, Kim HS, Shin YA, Shin HJ, Lee KR, Lee KY, Lee SY, Lee SK, Lee JH, Lee CB, Chung S, Cho YH, Choi KM, Han JS, Yoo SJ*; Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO). 2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea. J Obes Metab Syndr. 2019 Mar;28(1):40-45.
17. Cho JH, Rhee EJ, Park SE, Kwon H, Jung JH, Han KD, Park YG, Park HS, Kim YH, Yoo SJ, Lee WY; Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity. The Risk of Myocardial Infarction and Ischemic Stroke According to Waist Circumference in 21,749,261 Korean Adults: A Nationwide Population-Based Study. Diabetes Metab J. 2019;43(2):206-221.
18. Son JW, Kim CH, Nam MS, Park IB, Yoo SJ*. Efficacy and Safety of Prescription Omega-3 Fatty Acids Added to Stable Statin Therapy in Korean Patients with Type 2 Diabetes and Hypertriglyceridemia: a Randomized Controlled Trial. J Lipid Atheroscler. 2019 Sep;8(2):221-231.
19. Kim YH, Kim SM, Han KD, Jung JH, Lee SS, Oh SW, Park HS, Rhee EJ, Lee WY, Yoo SJ*. Waist Circumference and All-Cause Mortality Independent of Body Mass Index in Korean Population from the National Health Insurance Health Checkup 2009⁻2015. J Clin Med. 2019 Jan 10;8(1).
20. Cho JH, Rhee EJ, Par SE, Kwon H, Jung JH, Han KD, Park YG, Yoo SJ, Kim YH, Lee WY, Maintenance of body weight is an important determinant for the risk of ischemic stroke: A nationwide population-based cohort study. PLoS One. 2019 Jan 3;14(1):e0210153.